NEW YORK (Reuters) - Medical data research company Truveta said on Monday that Regeneron Pharmaceuticals, Illumina and 17 U.S. health systems will take a $320 million stake in the company as part of a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback